• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Azurity Pharmaceuticals Completes Acquisition of Covis Pharma PR Newswire
    March 14, 2025
    Azurity announced today the successful completion of its acquisition of Covis from existing investors.
  • AZ sells respiratory trio to Covis pharmatimes
    November 09, 2018
    Covis currently sells Alvesco, Omnaris and Zetonna in the US and will become the owner of the medicines. In return, it will pay AstraZeneca $350 million upon closing.
  • Sunovion Divests Asthma and Allergy Products to Covis americanpharmaceuticalreview
    July 18, 2017
    Sunovion has entered into a definitive agreement to divest the U.S. market rights to Sunovion’s ciclesonide products ALVESCO Inhalation Aerosol, OMNARIS Nasal Spray, and ZETONNA Nasal Aerosol to Covis Pharma. Ciclesonides are included in the corticosteroi

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service